EP1011535B1 - Surgical aid for connective tissue grafting - Google Patents
Surgical aid for connective tissue grafting Download PDFInfo
- Publication number
- EP1011535B1 EP1011535B1 EP98905140A EP98905140A EP1011535B1 EP 1011535 B1 EP1011535 B1 EP 1011535B1 EP 98905140 A EP98905140 A EP 98905140A EP 98905140 A EP98905140 A EP 98905140A EP 1011535 B1 EP1011535 B1 EP 1011535B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sheath
- graft
- mesh
- strands
- diameter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
- A61F2002/0847—Mode of fixation of anchor to tendon or ligament
- A61F2002/087—Anchor integrated into tendons, e.g. bone blocks, integrated rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
- A61F2002/0876—Position of anchor in respect to the bone
- A61F2002/0882—Anchor in or on top of a bone tunnel, i.e. a hole running through the entire bone
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
- Y10S623/908—Bone
Definitions
- This invention relates to a surgical aid.
- the surgical aid of the invention is particularly useful in connective tissue grafting procedures, such as ligament grafting as may be utilised in the surgical reconstruction of a joint.
- Connective tissue surgery can involve certain difficulties which are not experienced in other surgical procedures, in view of the significant tension which is often required to be endured by the connective tissue after surgery.
- a tissue graft is taken from healthy connective tissue and affixed in place of the damaged ligament. Because of the relatively high tensive load bearing requirements of the connective tissues in the knee joint, it is vitally important that the ends of the tissue graft attach securely at the bone insertion points. It is therefore desirable to enhance the fixation of the graft at each end thereof.
- a connective tissue graft may be required to be passed through bores which have been drilled in bone structures.
- the drilled bores are preferably as close in diameter as possible to the size of the end portions of the graft where the graft ends are to be attached therein.
- considerable force may be required in order to draw the tissue graft through the hole in order to overcome the frictional forces acting between the graft and aperture surface.
- suture it has been known to attach a suture to the end of the tissue graft for the purpose of drawing the graft through the aperture, but the suture can sometimes tear the graft tissue if pulled too hard.
- a tendon is located within a resorbable yam.
- the ends of the sheath are formed with loops which are engaged by a U-shaped member which is used to interconnect the loops with the graft and bone tissue.
- the sheath is located within an insertion tube, the head of which forms an anchoring device for one end of the graft.
- the present invention also utilises a bioabsorbable sheath but the sheath has different properties so that it can be used in novel and advantageous ways.
- PCT application WO 96/03084 discloses an arrangement for joining together or bracing severed or damaged connective tissue, consisting of an expansible mesh sheath which is slipped over the damaged or severed tissue.
- the sheath is axially shorter than the tissue it supports and radially contracts under axial tension to grip and support the damaged tissue.
- French patent application FR 2669527 A1 discloses an arrangement in which a piece of transplant tissue is enclosed in a sheet of mesh having anisotropic properties such that changes in longitudinal dimensions are independent of changes in transversal dimensions and vice versa.
- the mesh is substantially longitudinally inextensible. Opposed longitudinal edges are joined by lacing such that tightening the lacing causes the mesh to wrap around the tissue which becomes secured in position by circumferential tension.
- French patent application FR 272839A1 discloses an arrangement in which a piece of transplant tissue is pulled into a rigid tubular support which is in turn enclosed in a tubular mesh sheath which engages the rigid support while the transplant is being positioned.
- the rigid tubular support remains in situ until the transplant has been positioned in its intended location.
- the rigid support is then removed from the transplant. After removal of the support the sheath is longitudinally tensioned and the transplant and sheath are secured in position.
- European patent application 0328401 A1 teaches the provision of an anastomasis augmentation device consisting of an expandable sheath of biodegradable material which is used to repair broken ligaments or the like.
- the sheath is relatively axially short, and in use only covers the location of the brake and a short portion of ligament either side thereof, the ends of the sheaf being secured to the underlying tendon by stitching.
- the present invention provides a sheathing device for use in ligament grafting comprising: a holder for internally receiving a connective tissue graft and externally receiving a sheath including bioabsorbable fabric mesh material; said sheath having a first end and an intermediate portion in a radially expanded and an axially relaxed state mounted on an outer surface of the holder in which the sheath has a first expanded diameter and a reduced length; and said sheath having a second end in an axially tensioned and radially reduced state extending axially from the holder including a second diameter reduced from the first diameter, so that when the sheath and graft are simultaneously pulled from the holder, the sheath becomes elongated and the intermediate portion reduces in diameter, whereby the connective tissue graft is captured in the elongated, reduced diameter sheath and a substantial length of the sheath extends axially from opposite ends of the graft, in which the fabric mesh is formed from a number of interconnected strands,
- the material is formed as an open mesh fabric, the mesh size of which is 2.5 to 3.5mm (as measured when the sheath is flat and relaxed).
- the sheath has substantial linear expansion, preferably in the range from 10 to 20 times.
- a length of the sheath material in a relaxed state is say 30mm in length (and having a diameter of the order of say 20mm)
- it can be stretched to form a string or cord like structure having a length say of about 300mm.
- This enables the graft to be located in a central part of the sheath which is partly expanded and the end parts of the sheath to serve as strings or cords for use in insertion and placement of the graft.
- the sheath is preferably braided from a plurality of strands of thread or yarn.
- the sheath may be woven or knitted to form the tube structure, also preferably from a plurality of strands.
- the weave or knit pattern is preferably locked so that the sheath does not lose its integrity by running or the like if some of the strands are broken.
- the strands forming the sheath may all be constructed from a bioabsorbable material, although it is also possible for only a proportion of the strands to be bioabsorbable and the remaining strands constructed from non-absorbable biocompatible materials.
- bioabsorbable materials include polyglycolic acid (PGA) and polylactic acid (PLA) materials formed into fibres. Poliglecaprone and polydioxanone materials can also be utilised.
- the sheath is formed from 24 strands of suture material, each 4/O polyglycolic acid, interwoven into a tubular structure having a relaxed circumference of about 2 centimetres.
- the mesh sheath of preferred embodiments of the invention may additionally provide a framework for the impregnation of growth enhancing factors, cultured cells or other pharmacological agents, to aid in improved recovery from the graft surgery.
- the graft In use of the sheath for connective tissue graft surgery, the graft would typically be inserted into a section of the sheath material which is of a length so as to be somewhat longer than the graft itself. The ends of the sheath may then be pulled to apply tension to the sheath to facilitate the desired collapsing contraction of the sheath about the outside of the graft. With the graft ensheathed by the mesh, a component of axial tension applied to the sheath is transmitted to the graft itself. The graft may then be attached into its site of application with the sheath in place, and end portions of the sheath material trimmed away. Preferably the fixing means applied to the graft also fixes the sheath in place. For example where interference screws are used for attachment of the graft ends, the screws may be inserted through the sheath mesh, which can aid in fixation of the graft in the short term at least.
- a tubular mesh holder may be provided having a diameter sufficient to allow the graft to pass therethrough. The mesh holder is inserted into one end of the sheath tube and then the graft is passed through the mesh holder and into the sheath.
- the sheath of embodiments of the invention allows delivery of a graft held therein to its site of application without attaching sutures or the like to the graft itself, which therefore avoids potential damage to the graft during insertion.
- the sheath additionally provides a measure of protection to the graft by surrounding the graft during the insertion procedure. If desired, the graft may be maintained under tension during the insertion and attachment procedure by maintaining tension on the ends of the sheath.
- the sheath is fixed in place together with the graft, and is absorbed, or at least partially absorbed, over a period of time following insertion into the body.
- Anterior cruciate ligament reconstructive surgery is not an uncommon operation and is relatively successful, achieving acceptable results in the majority of patients undergoing the procedure.
- Most commonly, either the patella tendon or hamstring tendon are used as the basis for a graft of connective tissue, and each appear to have comparable results.
- a number of complications related to surgical technique can occur with both types of graft.
- the problems relate to the insertion of the graft, whether it be by open or arthroscopic methods, and the maintenance of the graft within the prepared drill holes.
- the graft be it bone-patella tendon-bone or hamstring tendon
- problems of fixation remain.
- a number of devices including interference fit screws and the endo-button have been used, but there are now a number of examples where these forms of fixation have been shown to be inadequate.
- a further additional problem which exists in relation to cruciate ligament reconstruction is accurate location of the isometric points of the anterior cruciate ligament and it has been conceived that embodiments of the present invention may have a role to play in improvement of this aspect of the surgery.
- the preferred form of the present invention is a sheathing device comprising a tubular mesh sheath of bio-absorbable thread designed to collapse and capture its contents.
- a specific purpose is to improve ligament and tissue grafting, such as in the reconstruction of the anterior cruciate ligament of the human knee.
- the sheath may be braided, woven or knitted, preferably from a plurality of strands of bioabsorbable material in such a way that axial tension applied to the sheath will cause the sheath to radially contract to ensheath a connective tissue graft, in use, therewithin. Furthermore, a component of the axial tension applied to the sheath is transmitted to the graft.
- the strands from which the sheath is constructed is are at least partially bioabsorbable so that the sheath is at least substantially absorbed by the patients body in the recovery period following the reconstructive surgery.
- Suitable materials from which the bioabsorbable strands may be formed include polyglycolic acid, polylactic acid, poliglecaprone and polydioxanone, although other bioabsorbable materials may alternatively be employed.
- Suitable bioabsorbable materials and also suitable non-absorbable biocompatible materials which may be used in conjunction with the bioabsorbable strands will be apparent to those skilled in the art from the disclosures of United States Patent Nos. 4,923,470 and 4,987,665, assigned to the American Cyanamid Company of Stamford, Connecticut USA.
- the sheath be formed from a plurality of strands in such a way that, if one strand breaks or is severed during use, the mesh structure of the remainder of the sheath is not adversely affected. This may be accomplished by the use of lock stitching or the like or by subjecting the sheath to heat in order to fuse the strands together where they are in contact with one another so as to thereby prevent running.
- an extruded tube of the material may be formed and slitted so as to form the expansible structure.
- the tubular sheath must be sufficiently radially expandable to allow a tissue graft to be inserted therein, and must be capable of contracting sufficiently to grasp the tissue graft therewithin when axial tension is applied.
- the sheath should be capable of expansion to a diameter significantly larger than that of the graft size, so that a tubular mesh holder can be inserted into an end of the sheath to facilitate insertion of the graft itself. It has been found that a sheath having a relaxed circumference of about 2 centimetres is appropriate for many applications.
- FIG. 1 shows a surgical aid 1 constructed in accordance with the invention.
- the surgical aid comprises a tubular mesh holder 22 having a hollow cylindrical body 21 formed with a rounded flange 23 at one end.
- a sheath 20 is mounted on the mesh holder 22.
- the other end of the body 21 includes a chamfer 3 and the free end of the sheath 20 would normally be spaced axially relative to the chamfer 3.
- the holder 22 is injection moulded from plastics material and has an inside diameter of about 9.5mm and a wall thickness of about 0.5mm. Its length including the chamfer 3 is preferably about 50mm.
- the flange 23 preferably projects outwardly by about 2mm.
- the surgical aid 1 can be used in conjunction with a graft 14.
- FIG 3 there is shown a diagrammatic representation of a human knee joint 2 shown from the front.
- the distal femoral process 4 and proximate processes of the tibia 6 and fibula 8 are shown, with the tibia coupled to the patella 10 by way of the patella ligament 12.
- a portion of the patella ligament 12 which is designated for removal to form the connective tissue graft is illustrated at 14, and shown removed and in greater detail in Figure 4.
- the graft 14 comprises a portion of the patella ligament connective tissue 14a coupled at one end to a small block of patella bone 14b and at the other end to a small block of tibial bone 14c.
- FIGs 5 to 7 are schematic. As shown in Figure 5, one end portion 20a is stretched from the chamfered end of the holder 22 so that about half the elongated length of the sheath 20 is removed. The graft 14 is then passed into the tubular mesh holder 22 from the flanged end 23 thereof until the end of the graft can be grasped at the other end of the mesh holder through the sheath portion 20a ( Figure 6). The graft is then held through the sheath material and drawn through the mesh holder 22 whilst the end of the sheath is pulled off the mesh holder ( Figure 7).
- the sheath is removed from the mesh holder 22 ( Figure 8) and to form the graft assembly 9 in which the graft 14 is ensheathed in an intermediate or central sheath 20c with extended end portions 20a and 20b of the sheath extending from the ends thereof.
- the length required of the tubular material of the sheath may depend upon the particular operation, but it is considered generally advantageous for additional length over the estimated required length to be provided since additional sheath material may be removed at the end of the procedure as described below.
- the extended length of the sheath 20 is preferably about 300mm and the graft 14 is typically less than about 100mm so that the end portions 20a and 20b are about 100mm in length and function like strings or cords as will be described below.
- Figure 9 is a side cross-sectional diagrammatic representation of the human knee joint to be reconstructed.
- Receiving apertures 30 and 31 have been drilled in the tibia and femur processes 6 and 4, respectively, and having a nominal diameter of 10mm.
- a narrower guide hole 32 extends from the aperture 31 to the superior surface of the femoral process 4.
- a guide wire 35 or the like extends through the guide hole 32 and receiving apertures 31 and 30 and out from the inferior surface of the tibial process 6 where it terminates at an eye 36 or other suitable attachment means.
- the end 20a of the graft assembly 9 is connected to the eye 36 of the guide wire by looping or tying the extended end portion 20a of the sheath material through the eye.
- the guide wire 35 is then pulled from the femoral end thereof in the direction generally indicated by arrow 37 so as to draw the ensheathed graft 14 through aperture 30. It may be desirable to maintain tension on the sheath 20 during this phase of the operation, by applying a suitable retarding force to the end portion 20b of the sheath. The surgeon can selectively pull the end portions 20a and 20b to correctly position the ends of the graft 14 in the apertures 30 and 31.
- the surgical site resembles the representation shown in Figure 10.
- the graft is in situ with one end bone block fitted into femoral receiving aperture 31 and the other end bone block fitted into tibial receiving aperture 30.
- the guide wire may now be removed, and the end portions 20a and 20b of the sheath 20 extend from the femur and tibia through the respective guide hole 32 and receiving aperture 30 opening.
- the grafting operation is completed by removing the extending end portions 20a, 20b of the sheath at or near the surfaces of the bones 4 and 6.
- the ends of the graft are now fixed within the receiving apertures.
- the graft fixation may be achieved in a number of ways, for example by coarse threaded interference fit screws 38, or the like, as are known in the art. Briefly, the screws are inserted in the apertures 31 and 32 so as to penetrate the gap (if any) between the bone blocks 14a and 14b and the apertures.
- the fixation means are applied through the material of the sheath so that the sheath is affixed in the joint along with the graft.
- the graft may be affixed at its ends whilst under tension, and to achieve that tension may be applied by pulling on the ends 20a and 20b of the sheath while the graft is attached. This causes both the sheath and graft to be under tension.
- the sheath will be at least substantially absorbed in a period of time following the surgical implantation thereof along with the graft. Whilst the sheath is in place it is able to relieve a portion of the strain which may be placed on the reconstructed tissue. However, not all of the strain is borne by the sheath to enable the graft to strengthen.
- various combinations of absorbable and non-absorbable material can be used to construct the mesh sheath of the present invention to alter to rate of degradation and permanent functional aspects of such grafts.
- different types of poly-absorbable materials may alter the rate of absorption time of the mesh.
- the sheath may be constructed to degrade more slowly and/or maintain a non-absorbable structural component.
- FIG. 1 schematically illustrates part of the mesh structure of the fabric of the tube 20. It will be seen that the mesh structure is relatively open having meshes 50 which are preferably square and having a mesh size in the range 2.5 to 3.5mm, when the sheath 20 is laid flat in a non-expanded position.
- Figure 2B schematically shows a knot-like structure 52 which is formed at the intersections between the meshes.
- the knot-like structure makes the fabric resistant to running or unravelling when some of the strands thereof are damaged or ruptured.
- the braiding machine produced a tubular sheath which when relaxed was about 1cm in diameter on the flat. Expansion was achieved by placing a cylindrical object within the tube up to its maximum diameter, and contraction was observed when ends of the tube were placed under tension.
- Dogs numbered one and two were sacrificed at six weeks, dog number three at twelve weeks, dogs numbered four to six at six weeks, dogs numbered seven to nine at twelve weeks and dogs numbered ten to twelve at twelve weeks.
- the drill hole could be seen through the femoral condyle on post-operative X-ray but no evidence of an osteolytic reaction around the mesh was seen.
- the results in the load testing machine demonstrated a two fold increase in resistance to disassociation of the graft from the bone when using the mesh when compared to not using the mesh.
- the mesh sheath works on a similar principle to that of a Chinese finger trap to gain a secure and strong hold on the graft. This means that unrestricted tension can be placed on the graft when it is being passed through the joint there by ensuring that it seats correctly in the prepared drill holes and does not "hang up” on any protuberance either within or at the margins of the hole or from anything within the joint.
- Ten tendons were fixed into 100 x 50 x 38 mm blocks of particle board. Those blocks had been drilled with a 10 mm diameter hole to accept the tendon. Fixation was achieved using a Smith & Nephew Richards R.C.I. 8 x 25 mm interference screw which was inserted to finish flush with the lower surface of the block. The free end of the tendon was held in a clamp arranged so that there would be negligible slip during distraction.
- Particle board was chosen as the bone substitute because of its uniformity, strength and its textural similarity to cancellous bone. The load failure of these specimens were extremely close to those of the fresh bovine bone previously tested.
- the mesh used was braided from 20 ends of 4/0 "Vicryl " material manufactured by Johnson & Johnson.
Landscapes
- Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
- This invention relates to a surgical aid. The surgical aid of the invention is particularly useful in connective tissue grafting procedures, such as ligament grafting as may be utilised in the surgical reconstruction of a joint.
- Connective tissue surgery can involve certain difficulties which are not experienced in other surgical procedures, in view of the significant tension which is often required to be endured by the connective tissue after surgery. For example, in the surgical reconstruction of the anterior cruciate ligament of a human knee, often a tissue graft is taken from healthy connective tissue and affixed in place of the damaged ligament. Because of the relatively high tensive load bearing requirements of the connective tissues in the knee joint, it is vitally important that the ends of the tissue graft attach securely at the bone insertion points. It is therefore desirable to enhance the fixation of the graft at each end thereof.
- Depending upon the particular surgical procedure employed, a connective tissue graft may be required to be passed through bores which have been drilled in bone structures. The drilled bores are preferably as close in diameter as possible to the size of the end portions of the graft where the graft ends are to be attached therein. Thus, sometimes considerable force may be required in order to draw the tissue graft through the hole in order to overcome the frictional forces acting between the graft and aperture surface. In previous surgical techniques it has been known to attach a suture to the end of the tissue graft for the purpose of drawing the graft through the aperture, but the suture can sometimes tear the graft tissue if pulled too hard. In the worst case the tissue graft may be ruined, with the result of serious consequences for the graft recipient. Further tension may be required to be applied to the graft during the surgical procedure in some instances where it is desirable for the graft to be under tension when surgically attached.
- Another technique has been proposed in US Patent No. 5,456,721 (Legrand). In that proposal, a tendon is located within a resorbable yam. In a first embodiment the ends of the sheath are formed with loops which are engaged by a U-shaped member which is used to interconnect the loops with the graft and bone tissue. In another technique, the sheath is located within an insertion tube, the head of which forms an anchoring device for one end of the graft. The present invention also utilises a bioabsorbable sheath but the sheath has different properties so that it can be used in novel and advantageous ways.
- PCT application WO 96/03084 discloses an arrangement for joining together or bracing severed or damaged connective tissue, consisting of an expansible mesh sheath which is slipped over the damaged or severed tissue. The sheath is axially shorter than the tissue it supports and radially contracts under axial tension to grip and support the damaged tissue.
- French patent application FR 2669527 A1 discloses an arrangement in which a piece of transplant tissue is enclosed in a sheet of mesh having anisotropic properties such that changes in longitudinal dimensions are independent of changes in transversal dimensions and vice versa. The mesh is substantially longitudinally inextensible. Opposed longitudinal edges are joined by lacing such that tightening the lacing causes the mesh to wrap around the tissue which becomes secured in position by circumferential tension.
- French patent application FR 272839A1 discloses an arrangement in which a piece of transplant tissue is pulled into a rigid tubular support which is in turn enclosed in a tubular mesh sheath which engages the rigid support while the transplant is being positioned. The rigid tubular support remains in situ until the transplant has been positioned in its intended location. The rigid support is then removed from the transplant. After removal of the support the sheath is longitudinally tensioned and the transplant and sheath are secured in position.
- European patent application 0328401 A1 teaches the provision of an anastomasis augmentation device consisting of an expandable sheath of biodegradable material which is used to repair broken ligaments or the like. The sheath is relatively axially short, and in use only covers the location of the brake and a short portion of ligament either side thereof, the ends of the sheaf being secured to the underlying tendon by stitching.
- The present invention provides a sheathing device for use in ligament grafting comprising: a holder for internally receiving a connective tissue graft and externally receiving a sheath including bioabsorbable fabric mesh material; said sheath having a first end and an intermediate portion in a radially expanded and an axially relaxed state mounted on an outer surface of the holder in which the sheath has a first expanded diameter and a reduced length; and said sheath having a second end in an axially tensioned and radially reduced state extending axially from the holder including a second diameter reduced from the first diameter, so that when the sheath and graft are simultaneously pulled from the holder, the sheath becomes elongated and the intermediate portion reduces in diameter, whereby the connective tissue graft is captured in the elongated, reduced diameter sheath and a substantial length of the sheath extends axially from opposite ends of the graft, in which the fabric mesh is formed from a number of interconnected strands, and the sheath is formed from strands of bioabsorbable material having a thickness in the range 0.06 to 0.55mm and preferably about 0.175mm.
- Preferably further, the material is formed as an open mesh fabric, the mesh size of which is 2.5 to 3.5mm (as measured when the sheath is flat and relaxed).
- Preferably further, the sheath has substantial linear expansion, preferably in the range from 10 to 20 times. For instance, if a length of the sheath material in a relaxed state is say 30mm in length (and having a diameter of the order of say 20mm), it can be stretched to form a string or cord like structure having a length say of about 300mm. This enables the graft to be located in a central part of the sheath which is partly expanded and the end parts of the sheath to serve as strings or cords for use in insertion and placement of the graft.
- The sheath is preferably braided from a plurality of strands of thread or yarn. Alternatively, the sheath may be woven or knitted to form the tube structure, also preferably from a plurality of strands. The weave or knit pattern is preferably locked so that the sheath does not lose its integrity by running or the like if some of the strands are broken.
- The strands forming the sheath may all be constructed from a bioabsorbable material, although it is also possible for only a proportion of the strands to be bioabsorbable and the remaining strands constructed from non-absorbable biocompatible materials. Some suitable bioabsorbable materials include polyglycolic acid (PGA) and polylactic acid (PLA) materials formed into fibres. Poliglecaprone and polydioxanone materials can also be utilised.
- In one particular form of the invention, the sheath is formed from 24 strands of suture material, each 4/O polyglycolic acid, interwoven into a tubular structure having a relaxed circumference of about 2 centimetres.
- The mesh sheath of preferred embodiments of the invention may additionally provide a framework for the impregnation of growth enhancing factors, cultured cells or other pharmacological agents, to aid in improved recovery from the graft surgery.
- In use of the sheath for connective tissue graft surgery, the graft would typically be inserted into a section of the sheath material which is of a length so as to be somewhat longer than the graft itself. The ends of the sheath may then be pulled to apply tension to the sheath to facilitate the desired collapsing contraction of the sheath about the outside of the graft. With the graft ensheathed by the mesh, a component of axial tension applied to the sheath is transmitted to the graft itself. The graft may then be attached into its site of application with the sheath in place, and end portions of the sheath material trimmed away. Preferably the fixing means applied to the graft also fixes the sheath in place. For example where interference screws are used for attachment of the graft ends, the screws may be inserted through the sheath mesh, which can aid in fixation of the graft in the short term at least.
- In order to facilitate insertion of the graft into the tube of sheath material, a tubular mesh holder may be provided having a diameter sufficient to allow the graft to pass therethrough. The mesh holder is inserted into one end of the sheath tube and then the graft is passed through the mesh holder and into the sheath.
- The sheath of embodiments of the invention allows delivery of a graft held therein to its site of application without attaching sutures or the like to the graft itself, which therefore avoids potential damage to the graft during insertion. The sheath additionally provides a measure of protection to the graft by surrounding the graft during the insertion procedure. If desired, the graft may be maintained under tension during the insertion and attachment procedure by maintaining tension on the ends of the sheath. The sheath is fixed in place together with the graft, and is absorbed, or at least partially absorbed, over a period of time following insertion into the body.
- The invention is described in greater detail hereinafter, by way of example only, with reference to the accompanying drawings, wherein:
- FIGURE 1 is a cross-sectional view through a device for assisting in grafting in accordance with the invention;
- FIGURE 2A is an enlarged schematic view of the mesh pattern of the sheath;
- FIGURE 2B is an enlarged schematic view of an intersection of the mesh pattern;
- FIGURE 3 is a schematic view of a human knee joint shown from the front illustrating removal of a portion of connective tissue;
- FIGURE 4 illustrates a graft of connective tissue;
- FIGURES 5 to 7 diagrammatically illustrate procedural steps for locating a graft in a sheath;
- FIGURE 8 diagrammatically illustrates a ligament graft assembly; and
- FIGURES 9, 10 and 11 are diagrammatic representations of a human knee joint shown from the side and illustrating the insertion of the graft therein with the use of the sheath.
-
- The principles of the invention will now be more fully described with reference to anterior cruciate ligament reconstructive surgery. It is to be understood, however, that this is by way of example only and the techniques of the invention are applicable in other forms of reconstructive surgery.
- Anterior cruciate ligament reconstructive surgery is not an uncommon operation and is relatively successful, achieving acceptable results in the majority of patients undergoing the procedure. Most commonly, either the patella tendon or hamstring tendon are used as the basis for a graft of connective tissue, and each appear to have comparable results. However, a number of complications related to surgical technique can occur with both types of graft. The problems relate to the insertion of the graft, whether it be by open or arthroscopic methods, and the maintenance of the graft within the prepared drill holes.
- With the increasing popularity of arthroscopic cruciate ligament reconstruction it has been a frequent observation that, when bone-patella tendon-bone grafts are used, difficulties can be encountered in the passage of the graft both through the tibial and femoral bone tunnels and through any soft tissue remnant within the knee. One of the problems concerns the adequate fixation of a suture to the bone-patella tendon-bone graft which will allow unrestricted force to be applied when attempting to engage the bone block in either of the tunnels.
- Once the graft, be it bone-patella tendon-bone or hamstring tendon, is located within the bone tunnels problems of fixation remain. A number of devices including interference fit screws and the endo-button have been used, but there are now a number of examples where these forms of fixation have been shown to be inadequate.
- A further additional problem which exists in relation to cruciate ligament reconstruction is accurate location of the isometric points of the anterior cruciate ligament and it has been conceived that embodiments of the present invention may have a role to play in improvement of this aspect of the surgery.
- The preferred form of the present invention is a sheathing device comprising a tubular mesh sheath of bio-absorbable thread designed to collapse and capture its contents. A specific purpose is to improve ligament and tissue grafting, such as in the reconstruction of the anterior cruciate ligament of the human knee. The sheath may be braided, woven or knitted, preferably from a plurality of strands of bioabsorbable material in such a way that axial tension applied to the sheath will cause the sheath to radially contract to ensheath a connective tissue graft, in use, therewithin. Furthermore, a component of the axial tension applied to the sheath is transmitted to the graft.
- The strands from which the sheath is constructed is are at least partially bioabsorbable so that the sheath is at least substantially absorbed by the patients body in the recovery period following the reconstructive surgery. Suitable materials from which the bioabsorbable strands may be formed include polyglycolic acid, polylactic acid, poliglecaprone and polydioxanone, although other bioabsorbable materials may alternatively be employed. Suitable bioabsorbable materials and also suitable non-absorbable biocompatible materials which may be used in conjunction with the bioabsorbable strands will be apparent to those skilled in the art from the disclosures of United States Patent Nos. 4,923,470 and 4,987,665, assigned to the American Cyanamid Company of Stamford, Connecticut USA.
- It is preferred that the sheath be formed from a plurality of strands in such a way that, if one strand breaks or is severed during use, the mesh structure of the remainder of the sheath is not adversely affected. This may be accomplished by the use of lock stitching or the like or by subjecting the sheath to heat in order to fuse the strands together where they are in contact with one another so as to thereby prevent running. In an alternative arrangement, an extruded tube of the material may be formed and slitted so as to form the expansible structure. The tubular sheath must be sufficiently radially expandable to allow a tissue graft to be inserted therein, and must be capable of contracting sufficiently to grasp the tissue graft therewithin when axial tension is applied. Preferably the sheath should be capable of expansion to a diameter significantly larger than that of the graft size, so that a tubular mesh holder can be inserted into an end of the sheath to facilitate insertion of the graft itself. It has been found that a sheath having a relaxed circumference of about 2 centimetres is appropriate for many applications.
- Figure 1 shows a surgical aid 1 constructed in accordance with the invention. The surgical aid comprises a
tubular mesh holder 22 having a hollowcylindrical body 21 formed with arounded flange 23 at one end. Asheath 20 is mounted on themesh holder 22. In this condition the diameter of thesheath 20 is somewhat expanded so that it snugly fits on thebody 21 and is prevented from falling off one end by means of the flange. The other end of thebody 21 includes a chamfer 3 and the free end of thesheath 20 would normally be spaced axially relative to the chamfer 3. Preferably, theholder 22 is injection moulded from plastics material and has an inside diameter of about 9.5mm and a wall thickness of about 0.5mm. Its length including the chamfer 3 is preferably about 50mm. Theflange 23 preferably projects outwardly by about 2mm. - As will be described in more detail below, the surgical aid 1 can be used in conjunction with a
graft 14. - In Figure 3 there is shown a diagrammatic representation of a human knee joint 2 shown from the front. The distal
femoral process 4 and proximate processes of thetibia 6 andfibula 8 are shown, with the tibia coupled to thepatella 10 by way of thepatella ligament 12. A portion of thepatella ligament 12 which is designated for removal to form the connective tissue graft is illustrated at 14, and shown removed and in greater detail in Figure 4. Thegraft 14 comprises a portion of the patella ligamentconnective tissue 14a coupled at one end to a small block ofpatella bone 14b and at the other end to a small block of tibial bone 14c. - Having obtained the
graft 14, the surgical aid 1 is employed to form aligament graft assembly 9 as shown in Figure 8. Figures 5 to 7 are schematic. As shown in Figure 5, oneend portion 20a is stretched from the chamfered end of theholder 22 so that about half the elongated length of thesheath 20 is removed. Thegraft 14 is then passed into thetubular mesh holder 22 from theflanged end 23 thereof until the end of the graft can be grasped at the other end of the mesh holder through thesheath portion 20a (Figure 6). The graft is then held through the sheath material and drawn through themesh holder 22 whilst the end of the sheath is pulled off the mesh holder (Figure 7). Finally, the sheath is removed from the mesh holder 22 (Figure 8) and to form thegraft assembly 9 in which thegraft 14 is ensheathed in an intermediate orcentral sheath 20c withextended end portions sheath 20 is preferably about 300mm and thegraft 14 is typically less than about 100mm so that theend portions - Figure 9 is a side cross-sectional diagrammatic representation of the human knee joint to be reconstructed. Receiving
apertures femur processes narrower guide hole 32 extends from theaperture 31 to the superior surface of thefemoral process 4. Aguide wire 35 or the like extends through theguide hole 32 and receivingapertures tibial process 6 where it terminates at aneye 36 or other suitable attachment means. Theend 20a of thegraft assembly 9 is connected to theeye 36 of the guide wire by looping or tying theextended end portion 20a of the sheath material through the eye. Theguide wire 35 is then pulled from the femoral end thereof in the direction generally indicated byarrow 37 so as to draw theensheathed graft 14 throughaperture 30. It may be desirable to maintain tension on thesheath 20 during this phase of the operation, by applying a suitable retarding force to theend portion 20b of the sheath. The surgeon can selectively pull theend portions graft 14 in theapertures - When the drawing of the graft into position is complete, the surgical site resembles the representation shown in Figure 10. At this stage the graft is in situ with one end bone block fitted into
femoral receiving aperture 31 and the other end bone block fitted intotibial receiving aperture 30. The guide wire may now be removed, and theend portions sheath 20 extend from the femur and tibia through therespective guide hole 32 and receivingaperture 30 opening. The grafting operation is completed by removing the extendingend portions bones - The ends of the graft are now fixed within the receiving apertures. The graft fixation may be achieved in a number of ways, for example by coarse threaded interference fit screws 38, or the like, as are known in the art. Briefly, the screws are inserted in the
apertures - In some instances it may be advantageous for the graft to be affixed at its ends whilst under tension, and to achieve that tension may be applied by pulling on the
ends - Depending upon the material used to construct the
sheath 20, the sheath will be at least substantially absorbed in a period of time following the surgical implantation thereof along with the graft. Whilst the sheath is in place it is able to relieve a portion of the strain which may be placed on the reconstructed tissue. However, not all of the strain is borne by the sheath to enable the graft to strengthen. - A number of advantages can be obtained through the utilisation of a sheathing device according to the present invention, as will be readily apparent to those skilled in the art from the foregoing and following description. Some of the advantageous effects include:
- 1. Enhancement of the delivery of a graft into its site of application because the
graft 14 is enclosed within the sheath, it is less likely to be obstructed during passage through the mounting apertures. - 2. Enhancement positioning of the ends of the graft in the mounting apertures by
manipulation of the
end portions - 3. Enhancement of the fixation of the graft at each end.
- 4. Gradual transfer of load from sheath to graft due to bio-absorption of the sheath material.
- 5. Avoidance of load transfer and stress shielding that were characteristics of previous augmentation devices.
- 6. The ability to maintain the graft under tension during and after insertion.
- 7. Enhanced adherence of synovial tissue to graft and enhanced revascularisation and cellular proliferation within the graft.
- 8. The provision of a framework for the impregnation of growth enhancing factors, cultured cells or other pharmacological agents.
- 9. Because the sheath is formed from locked or run resistant material, it will still
function even though some of the strands thereof may be damaged during the delivery
and positioning steps. In addition, as the fibres which form the
sheath 20 are gradually absorbed, the sheath will tend to maintain its integrity and thus avoid problems which might occur if portions of the sheath were to break away during the bioabsorption process. -
- It is also envisaged that various combinations of absorbable and non-absorbable material can be used to construct the mesh sheath of the present invention to alter to rate of degradation and permanent functional aspects of such grafts. For example, different types of poly-absorbable materials may alter the rate of absorption time of the mesh. Thus, where the surgeon, for example, believes that the tissue graft requires prosthetic support for a longer period of time, the sheath may be constructed to degrade more slowly and/or maintain a non-absorbable structural component.
- Whilst this invention was originally designed for use in anterior cruciate ligament reconstruction using the patella tendon or hamstring tendon, a wide range of applications are envisaged for the mesh such as in reconstructing the posterior cruciate ligament, the Achilles tendon, the biceps tendons in the arm and shoulder or the tendons surrounding the wrist. Other uses may be readily apparent to those skilled in the art from reading this description of the invention.
- Where a portion of hamstring tendon is to be used in knee construction surgery, it does not of course have the bone blocks at the ends. In this instance the part of the hamstring tendon which forms the graft is located within the sleeve in much the same way as described above. After placement of the ends of the graft in the receiving apertures, similar course threaded interference fit screws 38 are again used. In this application the material of the sheath is sandwiched between the graft and the screws and it has been found that significantly superior fixation occurs compared to known arrangements in which the operation is performed without the sleeve. It is thought that the increased improvement in fixation in this application would be more pronounced than in the case where blocks of bone are present at the ends of the graft.
- In a prototype construction the mesh sheath was formed by a commercial braiding process, although it is recognised that alternative manufacturing techniques may allow manufacture of a mesh of similar functionality. The mesh has been designed to maintain its integrity if failure of an individual strand occurs. In the prototype, a braiding machine normally used for making tachon lace was used because this is capable of braiding strands of the bioabsorbable material into an open mesh-like structure which is capable of substantial elongation. Figure 2 schematically illustrates part of the mesh structure of the fabric of the
tube 20. It will be seen that the mesh structure is relatively open havingmeshes 50 which are preferably square and having a mesh size in the range 2.5 to 3.5mm, when thesheath 20 is laid flat in a non-expanded position. Figure 2B schematically shows a knot-like structure 52 which is formed at the intersections between the meshes. The knot-like structure makes the fabric resistant to running or unravelling when some of the strands thereof are damaged or ruptured. In preparing theprototype sheath 20, twenty-four strands of bioabsorbable fibre were fed into the braiding machine. The fibre comprised 4/0 polyglycolic acid. The braiding machine produced a tubular sheath which when relaxed was about 1cm in diameter on the flat. Expansion was achieved by placing a cylindrical object within the tube up to its maximum diameter, and contraction was observed when ends of the tube were placed under tension. - Preliminary work was done using an artificial anterior cruciate ligament made of rubber to demonstrate that by applying tension to each end of the tube that tension would develop within the synthetic graft. Grafts were then manufactured to be suitable for insertion in adult greyhound dogs.
- Twelve dogs were chosen and anterior cruciate ligament reconstruction performed.
- In dogs numbered one to three a routine anterior cruciate ligament reconstruction using a strip of illiotibial band was used. The strip of fascia remained attached distally at the level of the knee joint and was passed through the intercondylar region and over the lateral femoral condyle and then reattached distal to the joint line. This would be considered equivalent to an "over the top" technique with lateral reinforcement in a human patient.
- In dogs numbered four to nine the same operation was performed but on these occasions the graft was contained within the poly-glycolic acid mesh.
- In dogs numbered ten to twelve the same source of graft covered with mesh was used but on this occasion the graft was passed through a drill hole in the lateral femoral condyle and then reattached distally.
- Dogs numbered one and two were sacrificed at six weeks, dog number three at twelve weeks, dogs numbered four to six at six weeks, dogs numbered seven to nine at twelve weeks and dogs numbered ten to twelve at twelve weeks.
- Histological examination of the joint fluid, synovial lining and anterior cruciate ligament graft was performed in all cases.
- The histological results were similar in all cases. There was no evidence of excessive fluid accumulation in the knee joints of those animals with mesh compared to those animals without mesh. There was no evidence of increased inflammatory response in those knees with mesh compared to those knees without mesh. There was no significant difference in the histological findings of the anterior cruciate ligament grafts with mesh or without mesh. There was no evidence of deleterious effect of the presence of mesh on graft or fibroblast formation within the graft.
- The drill hole could be seen through the femoral condyle on post-operative X-ray but no evidence of an osteolytic reaction around the mesh was seen.
- A second series of experiments was performed using beef femur. Graft from the patella tendon of beef was taken and fixed in the femoral condyle with the use of a fixation screw and subject to testing in a load testing machine. Comparisons were made between grafts inserted with and without the mesh.
- The results in the load testing machine demonstrated a two fold increase in resistance to disassociation of the graft from the bone when using the mesh when compared to not using the mesh.
- From this preliminary work it can be seen that the two fold aims of aiding the insertion and securing fixation using the mesh around an anterior cruciate ligament graft had been satisfied. Histological inspection demonstrated no deleterious effect of the presence of the mesh either on the joint itself or the graft.
- The mesh sheath works on a similar principle to that of a Chinese finger trap to gain a secure and strong hold on the graft. This means that unrestricted tension can be placed on the graft when it is being passed through the joint there by ensuring that it seats correctly in the prepared drill holes and does not "hang up" on any protuberance either within or at the margins of the hole or from anything within the joint.
- The tests have further demonstrated an additional benefit of the sheath to increase the security of fixation using interference fit screws. The results of load testing experiments of model cruciate graft implants for a comparison of mesh enhanced and non-mesh enhanced specimens are presented below.
- Twenty specimens of fresh bovine tendon were meticulously prepared by removal of peritenon and fat. The tendons were sized by trimming to 9.5mm diameter using a tubular gauge.
- Ten tendons were fixed into 100 x 50 x 38 mm blocks of particle board. Those blocks had been drilled with a 10 mm diameter hole to accept the tendon. Fixation was achieved using a Smith & Nephew Richards R.C.I. 8 x 25 mm interference screw which was inserted to finish flush with the lower surface of the block. The free end of the tendon was held in a clamp arranged so that there would be negligible slip during distraction.
- Collapsable bioabsorbable mesh sheath was applied to ten tendons using the mesh carrier. This totally covered the tendon and provided a cord to allow easy introduction of the tendon into the wooden block and tendon clamp at each end. These specimens were fixed in the same fashion as the previous ten.
- Testing was performed on a
Unitomatic TM 20 load testing apparatus coupled to an Ametec P.C. and software. A 2 kilo-Newton load cell was selected. Distraction speed was set at 50 mm per minute in line with other similar testing sighted in the literature. A graphic representation of stroke (mm) v's force (Newtons) was produced and the maximum force generated was accepted as (Newtons) was produced and the maximum force generated was accepted as the failure load of the specimen. All data was recorded via a dot matrix printer. - Particle board was chosen as the bone substitute because of its uniformity, strength and its textural similarity to cancellous bone. The load failure of these specimens were extremely close to those of the fresh bovine bone previously tested.
- The mesh used was braided from 20 ends of 4/0 "Vicryl " material manufactured by Johnson & Johnson.
-
-
1. Tendon
I 706.3 II. 621.0 III. 594.3 IV. 608.5 V. 723.3 VI. 690.0 VII. 800.3 VIII 717.3 IX 755.0 X 970.5 Average 718.6 -
2. Tendon with mesh
I 969.0 II. 928.0 III. 925.5 IV. 973.5 V. 919.5 VI. 920.0 VII. 920.5 VIII 1166.5 IX 627.0 screw failed by pulling out of block X 1190.0 Average 953.9 -
- All specimens were carefully observed for method of failure. In all cases bar one, the specimen failed when the tendon was pulled free of the interference screw. This left the screw embedded in the block and a noticeable gouge in the side of the tendon where it had been withdrawn across the tynes of the screw. In one exception, a mesh covered graft actually pulled the screw from the block causing the specimen to fail at a lower load.
- Close observation of failure of the mesh covered grafts showed that in all cases, except the above mentioned, rupturing of the mesh close to the point of fixation precipitated the failure of the specimen. This clearly indicated that the mesh was contributing substantially to the strength of the fixation.
- The use of the mesh increased the load force required for failure of the graft fixation by an average of 235.3 kN or 32.7%. If the single case of screw failure was excluded this figure rises to 37.8%. The additional strength of fixation corresponded to the previously measure strength of the mesh in situ. It is clear from this work that improving the strength of the mesh would result in yet higher failure loads.
- The foregoing detailed description has been presented by way of example only, and is not intended to be considered limiting to the invention, which is defined by the appended claims.
Claims (7)
- A sheathing device for use in ligament grafting comprising:a sheath (20), anda holder (22) for internally receiving a connective tissue graft (14) and externally receiving said sheath:said sheath having a first end (20a) and an intermediate portion in a radially expanded and an axially relaxed state mounted on an outer surface of the holder in which the sheath has a first expanded diameter and a reduced length; andsaid sheath (20) having a second end (20) in an axially tensioned and radially reduced state extending axially from the holder (22) including a second diameter reduced from the first diameter, so that when the sheath (20) and graft are simultaneously pulled from the holder (22), the sheath becomes elongated and the intermediate portion reduces in diameter, whereby the connective tissue graft (14) is captured in the elongated, reduced diameter sheath and a substantial length of the sheath (20a,20b) extends axially from opposite ends of the graft, wherein the fabric mesh is formed from a number of interconnected strands, characterised in that the sheath includes bioabsorbable fabric mesh material and the diameter of the strands is in the range of from 0.06 mm to 0.55 mm.
- A sheathing device as claimed in claim 1 wherein the mesh is of a size in the range of from 2.5 mm to 3.5 mm.
- A sheathing device as claimed in claim 1 wherein the interconnections between the strands of the fabric mesh are formed in such a manner as to resist running or decomposing when one or more of the strands are ruptured.
- A sheathing device as claim 3 wherein the strands which form the fabric mesh are partially fused in order to resist running or decomposing.
- A sheathing device as claimed in claim 3 wherein the strands comprise polyglycolic acid polymer.
- A sheathing device as claimed in claim 1 wherein the first diameter of the sheath is in the range of from 8mm to 15 mm.
- A sheathing device as claimed in claim 1 wherein the sheath (20) is extendable in length to at least five times its length from the axially relaxed state.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO5309A AUPO530997A0 (en) | 1997-02-25 | 1997-02-25 | Surgical aid for connective tissue grafting and method for employing same |
AUPO530997 | 1997-02-25 | ||
PCT/AU1998/000120 WO1998037835A1 (en) | 1997-02-25 | 1998-02-25 | Surgical aid for connective tissue grafting and method for employing same |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1011535A1 EP1011535A1 (en) | 2000-06-28 |
EP1011535A4 EP1011535A4 (en) | 2002-01-16 |
EP1011535B1 true EP1011535B1 (en) | 2005-12-14 |
Family
ID=3799612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98905140A Expired - Lifetime EP1011535B1 (en) | 1997-02-25 | 1998-02-25 | Surgical aid for connective tissue grafting |
Country Status (7)
Country | Link |
---|---|
US (1) | US6602290B2 (en) |
EP (1) | EP1011535B1 (en) |
AT (1) | ATE312573T1 (en) |
AU (1) | AUPO530997A0 (en) |
DE (1) | DE69832800T2 (en) |
ES (1) | ES2252825T3 (en) |
WO (1) | WO1998037835A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7651528B2 (en) | 2004-11-18 | 2010-01-26 | Cayenne Medical, Inc. | Devices, systems and methods for material fixation |
US7879094B2 (en) | 2006-10-24 | 2011-02-01 | Cayenne Medical, Inc. | Systems for material fixation |
US7967861B2 (en) | 2006-03-20 | 2011-06-28 | Cayenne Medical, Inc. | Devices, systems and methods for material fixation |
US8123806B1 (en) | 2008-05-09 | 2012-02-28 | Cayenne Medical, Inc | Method of tensioning a tissue graft having suture bundles using a cleated bar |
US8206446B1 (en) | 2009-03-10 | 2012-06-26 | Cayenne Medical, Inc. | Method for surgically repairing a damaged ligament |
US8858565B1 (en) | 2008-05-08 | 2014-10-14 | Cayenne Medical, Inc. | Inserter for soft tissue or bone-to-bone fixation device and methods |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050070906A1 (en) * | 1999-11-30 | 2005-03-31 | Ron Clark | Endosteal tibial ligament fixation with adjustable tensioning |
US7279008B2 (en) * | 2000-03-16 | 2007-10-09 | Smith & Nephew, Inc. | Sheaths for implantable fixation devices |
US6746483B1 (en) * | 2000-03-16 | 2004-06-08 | Smith & Nephew, Inc. | Sheaths for implantable fixation devices |
US7195642B2 (en) | 2001-03-13 | 2007-03-27 | Mckernan Daniel J | Method and apparatus for fixing a graft in a bone tunnel |
WO2002096269A2 (en) * | 2001-05-31 | 2002-12-05 | Coapt Systems, Inc. | Anterior cruciate ligament reconstruction system |
US20050065533A1 (en) * | 2001-05-31 | 2005-03-24 | Magen Hugh E. | Apparatus for assembling anterior cruciate ligament reconstruction system |
EP1334702B1 (en) * | 2002-02-08 | 2004-07-07 | Karl Storz GmbH & Co. KG | Anchor element to anchor a ligament transplant |
US20050058978A1 (en) * | 2003-09-12 | 2005-03-17 | Benevento Francis A. | Individualized learning system |
US7681195B2 (en) * | 2004-04-02 | 2010-03-16 | International Business Machines Corporation | System, method, and service for efficient allocation of computing resources among users |
US8323675B2 (en) | 2004-04-20 | 2012-12-04 | Genzyme Corporation | Soft tissue prosthesis for repairing a defect of an abdominal wall or a pelvic cavity wall |
CA2625264C (en) * | 2005-10-13 | 2015-12-15 | Synthes (U.S.A.) | Drug-impregnated sleeve for a medical implant |
JP2010522042A (en) | 2007-03-20 | 2010-07-01 | セリカ テクノロジーズ インコーポレイティッド | Tendon prosthesis and method of manufacturing the same |
US8795194B2 (en) | 2007-03-30 | 2014-08-05 | Smith & Nephew, Inc. | Tissue harvesting |
US20090105754A1 (en) * | 2007-10-12 | 2009-04-23 | Sethi Paul M | Tendon repair using tension-slide technique |
EP2259749A1 (en) * | 2008-03-13 | 2010-12-15 | Tavor (I.T.N) Ltd. | Ligament and tendon prosthesis |
US9138223B2 (en) * | 2009-02-19 | 2015-09-22 | Arthrex, Inc. | Drill pin for suture passing |
US8460350B2 (en) * | 2009-06-19 | 2013-06-11 | Arthrex, Inc. | Graft protection mesh and fixation technique |
TWI590843B (en) | 2011-12-28 | 2017-07-11 | 信迪思有限公司 | Films and methods of manufacture |
US9017404B2 (en) * | 2012-01-23 | 2015-04-28 | Lloyd P. Champagne | Devices and methods for tendon repair |
US8926662B2 (en) | 2012-02-01 | 2015-01-06 | Smith & Nephew, Inc. | Tissue graft anchoring |
US9204959B2 (en) | 2012-02-02 | 2015-12-08 | Smith & Nephew, Inc. | Implantable biologic holder |
WO2013142131A1 (en) * | 2012-03-23 | 2013-09-26 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Tissue graft anchoring |
WO2014011933A1 (en) | 2012-07-12 | 2014-01-16 | Exsomed Holding Company Llc | Metacarpal bone stabilization device |
US20140067062A1 (en) * | 2012-09-04 | 2014-03-06 | Mtp Solutions, Llc | Soft tissue graft and method |
US9232939B2 (en) | 2012-09-11 | 2016-01-12 | Biomet Sports Medicine, Llc | Flexible planar member for tissue fixation |
US9247936B2 (en) | 2012-09-20 | 2016-02-02 | Medos International Sarl | Suture leader |
EP2951193A4 (en) | 2013-02-01 | 2017-03-01 | Children's Medical Center Corporation | Collagen scaffolds |
US10052094B2 (en) | 2013-03-11 | 2018-08-21 | Medos International Sàrl | Implant having adjustable filament coils |
US9974643B2 (en) | 2013-03-11 | 2018-05-22 | Medos International Sàrl | Implant having adjustable filament coils |
US9585695B2 (en) | 2013-03-15 | 2017-03-07 | Woven Orthopedic Technologies, Llc | Surgical screw hole liner devices and related methods |
US20160144067A1 (en) | 2013-06-21 | 2016-05-26 | DePuy Synthes Products, Inc. | Films and methods of manufacture |
US9757113B2 (en) | 2013-07-31 | 2017-09-12 | Medos International Sàrl | Adjustable graft fixation device |
WO2015050895A1 (en) | 2013-10-02 | 2015-04-09 | Exsomed Holding Company Llc | Full wrist fusion device |
US10405968B2 (en) | 2013-12-11 | 2019-09-10 | Medos International Sarl | Implant having filament limbs of an adjustable loop disposed in a shuttle suture |
US9622523B2 (en) | 2014-01-06 | 2017-04-18 | Exsomed International IP, LLC | Ergonomic work gloves |
RU2016136578A (en) * | 2014-02-13 | 2018-03-19 | Антонио САМБУССЕТИ | NON-ABSORBABLE DEVICE FOR RECOVERY OF TISSUES, IN PARTICULAR SUCH TISSUES, AS LINKS |
US9993332B2 (en) | 2014-07-09 | 2018-06-12 | Medos International Sarl | Systems and methods for ligament graft preparation |
US8956394B1 (en) | 2014-08-05 | 2015-02-17 | Woven Orthopedic Technologies, Llc | Woven retention devices, systems and methods |
US9907593B2 (en) | 2014-08-05 | 2018-03-06 | Woven Orthopedic Technologies, Llc | Woven retention devices, systems and methods |
US9943351B2 (en) | 2014-09-16 | 2018-04-17 | Woven Orthopedic Technologies, Llc | Woven retention devices, systems, packaging, and related methods |
USD740427S1 (en) | 2014-10-17 | 2015-10-06 | Woven Orthopedic Technologies, Llc | Orthopedic woven retention device |
US10182808B2 (en) | 2015-04-23 | 2019-01-22 | DePuy Synthes Products, Inc. | Knotless suture anchor guide |
US10441330B2 (en) | 2015-05-19 | 2019-10-15 | Exsomed Holding Company, Llc | Distal radius plate |
US20180221059A1 (en) | 2015-08-05 | 2018-08-09 | Woven Orthopedic Technologies, Llc | Tapping devices, systems and methods for use in bone tissue |
US9931196B2 (en) * | 2015-08-26 | 2018-04-03 | Albert Einstein Healthcare Network | Connector for attaching tissue to bone |
US10383720B2 (en) | 2015-12-22 | 2019-08-20 | DePuy Synthes Products, Inc. | Graft preparation system |
US10245091B2 (en) | 2015-12-30 | 2019-04-02 | Exsomed Holding Company, Llc | Dip fusion spike screw |
US11147604B2 (en) | 2016-01-12 | 2021-10-19 | ExsoMed Corporation | Bone stabilization device |
US10194923B2 (en) | 2016-05-10 | 2019-02-05 | Exsomed International IP, LLC | Tool for percutaneous joint cartilage destruction and preparation for joint fusion |
EP3551105A4 (en) | 2016-12-09 | 2020-07-29 | Woven Orthopedic Technologies, LLC | Retention devices, lattices and related systems and methods |
US11147681B2 (en) | 2017-09-05 | 2021-10-19 | ExsoMed Corporation | Small bone angled compression screw |
AU2018328102C1 (en) | 2017-09-05 | 2023-08-03 | ExsoMed Corporation | Intramedullary threaded nail for radial cortical fixation |
US11191645B2 (en) | 2017-09-05 | 2021-12-07 | ExsoMed Corporation | Small bone tapered compression screw |
US10881762B2 (en) * | 2017-11-15 | 2021-01-05 | De Novo Orthopedics Inc. | Method for manufacturing bioinductive patch |
CN117796865B (en) * | 2024-02-23 | 2024-06-18 | 浙江大学医学院附属第一医院(浙江省第一医院) | Tendon fixing device for reconstructing cruciate ligament |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5456721A (en) * | 1991-07-11 | 1995-10-10 | Legrand; Jean-Jacques | Device for reinforcing a ligament transplant during reconstructive surgery |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3971670A (en) * | 1974-07-17 | 1976-07-27 | Homsy Charles A | Implantable structure and method of making same |
US4455690A (en) * | 1980-11-06 | 1984-06-26 | Homsy Charles A | Structure for in vivo implanation |
US4467478A (en) | 1982-09-20 | 1984-08-28 | Jurgutis John A | Human ligament replacement |
GB8525565D0 (en) * | 1985-10-17 | 1985-11-20 | Speedhom B B | Surgical replacement of ligaments |
US4743252A (en) | 1986-01-13 | 1988-05-10 | Corvita Corporation | Composite grafts |
US4792336A (en) | 1986-03-03 | 1988-12-20 | American Cyanamid Company | Flat braided ligament or tendon implant device having texturized yarns |
US4987665A (en) | 1986-03-03 | 1991-01-29 | American Cyanamid Company | Prosthetic tubular article |
US5425766A (en) * | 1987-03-09 | 1995-06-20 | Astra Tech Aktiebolag | Resorbable prosthesis |
EP0328401A1 (en) | 1988-02-11 | 1989-08-16 | Unisearch Limited | Anastomosis augmentation device |
US4883486A (en) * | 1988-05-31 | 1989-11-28 | Indu Kapadia | Prosthetic ligament |
FR2662601B1 (en) * | 1990-06-01 | 1994-06-10 | Coisy Michel | NEW ARTIFICIAL LIGAMENT IMPLANT. |
FR2669527B1 (en) * | 1990-11-23 | 1998-12-11 | Asa Laboratoires Prothaid | REINFORCEMENT ORTHESIS FOR THE REPLACEMENT OF A DEFICIENT LIGAMENT BY AN AUTOLOGOUS TRANSPLANT. |
WO1996003084A1 (en) * | 1994-07-26 | 1996-02-08 | University Of Akron, The | Device and method for restoration of connective tissue |
US5671695A (en) * | 1994-07-28 | 1997-09-30 | Depuy Inc. | Replacement ligament graft passer and method |
FR2724839B1 (en) * | 1994-09-28 | 1997-04-25 | Cousin Freres Sa | DEVICE FOR POSITIONING AN IMPLANT IN RESTORATIVE SURGERY |
FR2745710B1 (en) * | 1996-03-11 | 1998-05-29 | Rippstein Pascal Francois | TENDON PASSING DEVICE |
-
1997
- 1997-02-25 AU AUPO5309A patent/AUPO530997A0/en not_active Abandoned
-
1998
- 1998-02-25 US US09/380,210 patent/US6602290B2/en not_active Expired - Fee Related
- 1998-02-25 AT AT98905140T patent/ATE312573T1/en not_active IP Right Cessation
- 1998-02-25 DE DE69832800T patent/DE69832800T2/en not_active Expired - Lifetime
- 1998-02-25 WO PCT/AU1998/000120 patent/WO1998037835A1/en active IP Right Grant
- 1998-02-25 EP EP98905140A patent/EP1011535B1/en not_active Expired - Lifetime
- 1998-02-25 ES ES98905140T patent/ES2252825T3/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5456721A (en) * | 1991-07-11 | 1995-10-10 | Legrand; Jean-Jacques | Device for reinforcing a ligament transplant during reconstructive surgery |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7651528B2 (en) | 2004-11-18 | 2010-01-26 | Cayenne Medical, Inc. | Devices, systems and methods for material fixation |
US8435294B2 (en) | 2004-11-18 | 2013-05-07 | Cayenne Medical, Inc. | Devices, systems and methods for material fixation |
US8465545B2 (en) | 2006-03-20 | 2013-06-18 | Cayenne Medical, Inc. | Devices, systems, and methods for material fixation |
US7967861B2 (en) | 2006-03-20 | 2011-06-28 | Cayenne Medical, Inc. | Devices, systems and methods for material fixation |
US8192490B2 (en) | 2006-10-24 | 2012-06-05 | Cayenne Medical, Inc. | Methods and systems for material fixation |
US8414647B2 (en) | 2006-10-24 | 2013-04-09 | Cayenne Medical, Inc. | Systems for material fixation |
US7879094B2 (en) | 2006-10-24 | 2011-02-01 | Cayenne Medical, Inc. | Systems for material fixation |
US8652208B2 (en) | 2006-10-24 | 2014-02-18 | Cayenne Medical, Inc. | Methods and systems for material fixation |
US9597175B2 (en) | 2006-10-24 | 2017-03-21 | Cayenne Medical, Inc. | Methods and systems for material fixation |
US10117739B2 (en) | 2006-10-24 | 2018-11-06 | Cayenne Medical, Inc. | Methods and systems for material fixation |
US10959832B2 (en) | 2006-10-24 | 2021-03-30 | Cayenne Medical, Inc. | Methods and systems for material fixation |
US8858565B1 (en) | 2008-05-08 | 2014-10-14 | Cayenne Medical, Inc. | Inserter for soft tissue or bone-to-bone fixation device and methods |
US9901437B1 (en) | 2008-05-08 | 2018-02-27 | Cayenne Medical, Inc. | Inserter for soft tissue or bone-to-bone fixation device and methods |
US8123806B1 (en) | 2008-05-09 | 2012-02-28 | Cayenne Medical, Inc | Method of tensioning a tissue graft having suture bundles using a cleated bar |
US8790357B1 (en) | 2008-05-09 | 2014-07-29 | Cayenne Medical, Inc. | Manual soft tissue T-shape tensioning device |
US8206446B1 (en) | 2009-03-10 | 2012-06-26 | Cayenne Medical, Inc. | Method for surgically repairing a damaged ligament |
US8870955B1 (en) | 2009-03-10 | 2014-10-28 | Cayenne Medical, Inc. | Methods and systems for material fixation |
Also Published As
Publication number | Publication date |
---|---|
WO1998037835A1 (en) | 1998-09-03 |
EP1011535A1 (en) | 2000-06-28 |
DE69832800D1 (en) | 2006-01-19 |
EP1011535A4 (en) | 2002-01-16 |
AUPO530997A0 (en) | 1997-03-20 |
DE69832800T2 (en) | 2006-08-03 |
ES2252825T3 (en) | 2006-05-16 |
US20020055749A1 (en) | 2002-05-09 |
US6602290B2 (en) | 2003-08-05 |
ATE312573T1 (en) | 2005-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1011535B1 (en) | Surgical aid for connective tissue grafting | |
US11896210B2 (en) | Method and apparatus for coupling soft tissue to a bone | |
US11413132B2 (en) | Systems and methods for ligament graft preparation | |
US5456721A (en) | Device for reinforcing a ligament transplant during reconstructive surgery | |
JP5615891B2 (en) | Tendon prosthesis and method of manufacturing the same | |
US11517420B2 (en) | Systems and methods for preparing reinforced graft constructs | |
US20040225358A1 (en) | Apparatus and method for reconstructing a ligament | |
CA2353206C (en) | Apparatus and method for reconstructing a ligament | |
EP2892463B1 (en) | Synthetic ligament assembly | |
AU761989B2 (en) | Surgical aid for connective tissue grafting and method for employing same | |
AU731936B2 (en) | Surgical aid for connective tissue grafting and method for employing same | |
AU743846B2 (en) | Surgical aid for connective tissue grafting and method for employing same | |
KR100283928B1 (en) | Ligament Fixation Screw for Knee Cruciate Reconstruction | |
US20240081807A1 (en) | Method and apparatus for coupling soft tissue to a bone | |
KR20240015748A (en) | Backstop loader |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19990914 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 19990914;LT PAYMENT 19990914;LV PAYMENT 19990914;MK PAYMENT 19990914;RO PAYMENT 19990914;SI PAYMENT 19990914 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20011203 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61F 2/08 A, 7A 61B 17/11 B |
|
17Q | First examination report despatched |
Effective date: 20030206 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RTI1 | Title (correction) |
Free format text: SURGICAL AID FOR CONNECTIVE TISSUE GRAFTING |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20051214 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20051214 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20051214 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20051214 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 69832800 Country of ref document: DE Date of ref document: 20060119 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060227 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060228 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20060228 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20060228 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060314 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060314 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060314 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: E. BLUM & CO. PATENTANWAELTE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060515 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2252825 Country of ref document: ES Kind code of ref document: T3 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20051214 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20060915 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: ESNOUF, PHILIP STUART Free format text: ESNOUF, PHILIP STUART#243 KOOYONG ROAD#TOORAK, VIC 3142 (AU) $ LOVE, BRUCE RICHARD TYLDEN#518 VICTORIA PARADE#EAST MELBOURNE, VIC 3002 (AU) -TRANSFER TO- ESNOUF, PHILIP STUART#243 KOOYONG ROAD#TOORAK, VIC 3142 (AU) $ LOVE, BRUCE RICHARD TYLDEN#518 VICTORIA PARADE#EAST MELBOURNE, VIC 3002 (AU) |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20090312 Year of fee payment: 12 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070225 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20110329 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110316 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100226 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20120313 Year of fee payment: 15 Ref country code: FR Payment date: 20120319 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20120307 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20120307 Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20130225 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130228 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130228 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20131031 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 69832800 Country of ref document: DE Effective date: 20130903 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130903 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130228 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130225 |